ALAA AHMED: Open Payments
NPI 1144742230 · CARBONDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,345 in 79 payments from 14 companies in 2025. Trend: 2023 $427 · 2024 $1,261 · 2025 $1,345
Food & beverage: $1,345
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $223 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $176 |
| Lundbeck LLC | 9 | $166 |
| Alkermes, Inc. | 10 | $163 |
| ABBVIE INC. | 15 | $158 |
| Axsome Therapeutics, Inc. | 6 | $123 |
| Neurocrine BioSciences, Inc. | 4 | $81 |
| Vanda Pharmaceuticals Inc. | 3 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
Products named: REXULTI, CAPLYTA, VRAYLAR, Auvelity, ARISTADA, INGREZZA, ABILIFY MAINTENA, FANAPT.
Industry payments across IL — which companies pay providers there.
